More and more people who have been injured or think they've been injured come forward. It takes on a life of its own.
Most people predicted this but it wasn't a forgone conclusion.
Most people watching this litigation closely thought that Merck ought to win it. Despite the characterizations by Merck so far, I think this was really a loss for them.
Merck is trying to paint this as a tie, but it is really not so good for them because people thought they would have had an easy win.
It's too soon to say Merck has momentum. Many people felt the Irvin case was a weak case to begin with. It was a short-term usage case.
All the survivors and families of people who perished on 9/11 will be called, and it's hard to imagine how to counter any of that.
It's too early to tell. Some people believe that Roberts may be similar to Rehnquist in his jurisprudence, although that's not at all clear yet.